Search

Yttrium and aluminium co-substitutions on lanthanum molybdate ceramics with the nominal formula La1.75Y0.25Mo2-xAlxO9-δδ (LYMA, x = 0, 0.1, 0.2, 0.3 and 0.4) were synthesized by citric acid-nitrate combustion method and used for preparation of solid electrolyte for intermediate-temperature solid oxide fuel cells (ITSOFCs). Phase composition, structure, conductivity and electrical properties of LYMA have been investigated as a function of aluminium content by X-ray diffraction, scanning electron microscopy and electrochemical impedance spectroscopy, respectively. Experimental results showed that the substitution of La and Mo with appropriate amounts of Y and Al can effectively stabilize the β-form of La2Mo2O9 at room temperature and inhibit its phase transition to α-form. The LYMA synthesized by combustion method exhibited a better sinterability where relative density of the samples sintered at 950°C for 4 h was higher than 95%TD. The performance of the LYMA electrolyte was found to be related to Al-content. The La1.75Y0.25Mo1.8Al0.2O8.7 exhibited high oxide ion conductivity (σ= 42mS/cm at 800°C) and low electrical activation energy (Ea = 1.18 eV). These preliminary results indicate that the LYMA is a promising electrolyte for IT-SOFCs.

Samarium, gadolinium, and yttrium co-doped ceria (Ce0.8Sm0.16Y0.03Gd0.01O1.9, CSYG) and BaIn0.3Ti0.7O2.85 (BIT07) powders were prepared by sol-gel and solid-state reaction methods, respectively. CSYG-BIT07 composite materials were obtained by mechanically mixing the two powders in different ratios and calcining at 1300 °C for 5 h. Samples were characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM), as well as electrical properties and thermal expansion coefficient (TEC) measurements. A series of CSYG-BIT07 composite materials with relative densities higher than 95% were fabricated by sintering at 1300 °C for 5 h. The performance of the CSYG-BIT07 composite electrolyte was found to be related to the content of BIT07. The CSYG-15% BIT07 composite exhibited high oxide ion conductivity (σ800°C = 0.0126 S·cm−1 at 800 °C), moderate thermal expansion (TEC = 9.13 × 10−6/K between room temperature and 800 °C), and low electrical activation energy (Ea = 0.89 eV). These preliminary results indicate that the CSYG-BIT07 material is a promising electrolyte for intermediate-temperature solid oxide fuel cells (IT-SOFCs). [ABSTRACT FROM AUTHOR]

Introduction: Immune checkpoint (IC) inhibitor-related immunotherapies have attracted considerable attention in hepatocellular carcinoma (HCC). High IC expression and high tumor infiltrating lymphocyte levels are the current indicators of sensitivity to IC inhibitors. Thus, it is imperative to apply precision medicine strategies for patient selection., Methods: Six independent HCC cohorts were used for analysis at the single-cell and tissue levels. Multiplex immunofluorescence and immunochemistry staining assays were used to validate our results. A series of methodologies were used for immune-related evaluations., Results: Herein, we uncovered a unique CD8 + CD274 + cell subpopulation that is associated with tumor progression and poor survival in HCC at the single-cell level. We assessed this subset at the tissue level and found that the prognostic significance of CD274 is dependent on CD8A expression in HCC. Subsequently, we identified a unique high-risk subpopulation that showed high CD8A expression coupled with intense CD274 expression in multiple HCC cohorts. CD8A High CD274 High* subgroup was correlated with malignant indexes and remained an independent prognostic factor when considering the influence of these indexes. Molecular characteristic analyses showed that the CD8A High CD274 High* subgroup harbored more mutations, had higher immune response activity and presented enrichment of cancer-related biological processes. Moreover, this high-risk subpopulation in HCC was characterized by high immune cell infiltration, low tumor purity, and enrichment of cancer-related signatures. Finally, cases with this phenotype demonstrated higher immunomodulator and IC levels and greater sensitivity to IC inhibitors., Conclusion: Our findings illustrate that some HCC patients may have a poor prognosis despite high CD8 + T-cell infiltration. These patients would probably benefit from IC inhibitor-based combination treatment., Competing Interests: The authors declare that they have no competing interests in this work., (© 2023 Zhang et al.)